Literature DB >> 2244374

HIV antibody seroprevalence among prisoners entering the California correctional system.

J A Singleton1, C I Perkins, A I Trachtenberg, M J Hughes, K W Kizer, M Ascher.   

Abstract

A cross-sectional blind study was conducted in the spring of 1988 to estimate the extent of human immunodeficiency virus (HIV) infection among inmates entering the California correctional system. Of the 6,834 inmates receiving entrance physical examinations during the study period, 6,179 (90.4%) had serum tested for the presence of HIV antibodies after routine blood work was completed and personal identifiers were removed. Seroprevalence was 2.5% (95% confidence interval, 2.1% to 3.0%) among the 5,372 men tested and 3.1% (95% confidence interval, 2.1% to 4.5%) among the 807 women tested. Seroprevalence was more than twice as high among men arrested in the San Francisco Bay Area as in those arrested elsewhere in the state. The regional differences in HIV seroprevalence observed among entering inmates mirror infection rates reported among intravenous drug users from the same regions.

Entities:  

Mesh:

Year:  1990        PMID: 2244374      PMCID: PMC1002568     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  11 in total

1.  Prevalence and incidence of HTLV-III infection in a prison.

Authors:  P W Kelley; R R Redfield; D L Ward; D S Burke; R N Miller
Journal:  JAMA       Date:  1986 Oct 24-31       Impact factor: 56.272

2.  Transmission of HIV-1 within a statewide prison system.

Authors:  T F Brewer; D Vlahov; E Taylor; D Hall; A Munoz; B F Polk
Journal:  AIDS       Date:  1988-10       Impact factor: 4.177

3.  The incidence of hepatitis B in Tennessee prisoners.

Authors:  M D Decker; W K Vaughn; J S Brodie; R H Hutcheson; W Schaffner
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

4.  Incidence of hepatitis B in the penitentiary of New Mexico.

Authors:  H F Hull; L H Lyons; J M Mann; S C Hadler; R Steece; M R Skeels
Journal:  Am J Public Health       Date:  1985-10       Impact factor: 9.308

5.  Drug histories and criminality: survey of inmates of state correctional facilities, January 1974.

Authors:  W I Barton
Journal:  Int J Addict       Date:  1980-02

6.  Multiple drug abuse: examination of drug-abuse patterns in male prisoners.

Authors:  J L Marini; C I Bridges; M H Sheard
Journal:  Int J Addict       Date:  1978-04

7.  HIV testing in prisoners: is mandatory testing mandatory?

Authors:  J K Andrus; D W Fleming; C Knox; R O McAlister; M R Skeels; R E Conrad; J M Horan; L R Foster
Journal:  Am J Public Health       Date:  1989-07       Impact factor: 9.308

8.  Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men.

Authors:  S M Wolinsky; C R Rinaldo; S Kwok; J J Sninsky; P Gupta; D Imagawa; H Farzadegan; L P Jacobson; K S Grovit; M H Lee
Journal:  Ann Intern Med       Date:  1989-12-15       Impact factor: 25.391

9.  Health status of the New York City prison population.

Authors:  L F Novick; R D Penna; M S Schwartz; E Remmlinger; R Loewenstein
Journal:  Med Care       Date:  1977-03       Impact factor: 2.983

10.  Seroprevalence of HIV antibody among individuals entering the Iowa Prison System.

Authors:  G E Glass; W J Hausler; P L Loeffelholz; C E Yesalis
Journal:  Am J Public Health       Date:  1988-04       Impact factor: 9.308

View more
  5 in total

Review 1.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

2.  Transmission of Mycobacterium tuberculosis in a California State Prison, 1991.

Authors:  D T Koo; R C Baron; G W Rutherford
Journal:  Am J Public Health       Date:  1997-02       Impact factor: 9.308

3.  Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system.

Authors:  J D Ruiz; F Molitor; R K Sun; J Mikanda; M Facer; J M Colford; G W Rutherford; M S Ascher
Journal:  West J Med       Date:  1999-03

4.  Seroprevalence of HIV-type 1 in a northern California health plan population: an unlinked survey.

Authors:  R A Hiatt; F J Capell; M S Ascher
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

Review 5.  Global View of HIV Prevalence in Prisons: A Systematic Review and Meta-Analysis.

Authors:  Mehdi Sayyah; Fakher Rahim; Gholam Abbas Kayedani; Kiarash Shirbandi; Amal Saki-Malehi
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.